Latest Articles
Hope Medicine Ready To Bring Potential First-in-Class Endometriosis Treatment Into Phase III - insights.citeline.com
Hope Medicine Ready To Bring Potential First-in-Class Endometriosis Treatment Into Phase III insights.citeline.com
Published: Oct. 8, 2025, 2:15 p.m.
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - Vulcan Post
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment Vulcan Post
Published: Oct. 8, 2025, 7:33 a.m.
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - The Malaysian Reserve
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment The Malaysian Reserve
Published: Oct. 8, 2025, 2:14 a.m.
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - Fidelity
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment Fidelity
Published: Oct. 8, 2025, 1:35 a.m.
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - The Manila Times
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment The Manila Times
Published: Oct. 8, 2025, 1:23 a.m.
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - PR Newswire
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment PR Newswire
Published: Oct. 8, 2025, 1:08 a.m.
United States Endometriosis Treatment Market Report 2025: Pain - openPR.com
United States Endometriosis Treatment Market Report 2025: Pain openPR.com
Published: Sept. 29, 2025, 10:32 a.m.
Swedish Biotech Gesynta Advances Non-Hormonal Endometriosis Treatment - insights.citeline.com
Swedish Biotech Gesynta Advances Non-Hormonal Endometriosis Treatment insights.citeline.com
Published: Sept. 25, 2025, 7:42 a.m.
AbbVie’s Phase 3b Study on Elagolix: A Potential Game-Changer for Endometriosis Treatment? - TipRanks
AbbVie’s Phase 3b Study on Elagolix: A Potential Game-Changer for Endometriosis Treatment? TipRanks
Published: Sept. 6, 2025, 4:33 a.m.
IceCure Medical’s ProSense® Shows Promising Results in Endometriosis Treatment - TipRanks
IceCure Medical’s ProSense® Shows Promising Results in Endometriosis Treatment TipRanks
Published: Sept. 4, 2025, 1:23 p.m.
Link copied to clipboard!